Ryutaro Onaga

Department Of Head And Neck Medical Oncology
Kashiwa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow.

Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow.

Journal: Human pathology

Published: January 18, 2026

Significance of Preoperative Imaging-Detected Extranodal Extension in Pathological Extranodal Extension-Positive Head and Neck Squamous Cell Carcinoma Treated With Postoperative Chemoradiotherapy.

Significance of Preoperative Imaging-Detected Extranodal Extension in Pathological Extranodal Extension-Positive Head and Neck Squamous Cell Carcinoma Treated With Postoperative Chemoradiotherapy.

Journal: Head & neck

Published: December 26, 2025

Intracranial antitumor efficacy of combination treatment with encorafenib plus binimetinib in BRAF V600E-mutated anaplastic thyroid carcinoma.

Intracranial antitumor efficacy of combination treatment with encorafenib plus binimetinib in BRAF V600E-mutated anaplastic thyroid carcinoma.

Journal: Auris, nasus, larynx

Published: September 19, 2025

Surgical outcome of primary hyperparathyroidism and factors correlated with preoperative serum iPTH concentration.

Surgical outcome of primary hyperparathyroidism and factors correlated with preoperative serum iPTH concentration.

Journal: Auris, nasus, larynx

Published: August 08, 2025

Imaging-detected extranodal extension in head and neck cancer: clinical implications, diagnostic criteria, and the potential of photon-counting detector CT.

Imaging-detected extranodal extension in head and neck cancer: clinical implications, diagnostic criteria, and the potential of photon-counting detector CT.

Journal: Japanese journal of radiology

Published: July 08, 2025

Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan.

Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan.

Journal: Thyroid : official journal of the American Thyroid Association

Published: June 09, 2025

Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer.

Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer.

Journal: International journal of clinical oncology

Published: February 05, 2025

LH-RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study.

LH-RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study.

Journal: International journal of clinical oncology

Published: December 16, 2024

Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy.

Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy.

Journal: Oral oncology

Published: September 20, 2024

The association between initiation weekday of radiotherapy and local control in stage 1 glottic carcinoma: a retrospective analysis.

The association between initiation weekday of radiotherapy and local control in stage 1 glottic carcinoma: a retrospective analysis.

Journal: Journal of radiation research

Published: May 01, 2024

Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer.

Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer.

Journal: International journal of clinical oncology

Published: April 27, 2024

Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE).

Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE).

Journal: Oral oncology

Published: February 15, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026